Studies in tumour-bearing mice have demonstrated that the exhaustion pathway is established early during tumourigenesis [29], has an epigenetic signature distinct from the effector pathway [30], and is established and maintained by the action of the transcription factor and epigenetic modifier TOX [31,32,33,34,35,36,37,38]. This evidence concerns the gene TOX and neoplasm.